Four cardiac hormones cause death of human cancer cells but not of healthy cells

Anticancer Research

Volumn 31, Issue 2, 2011, Pages 395-402

  Skelton IV, William P ^a   Pi, Guillermo E ^b   Vesely, David L ^c  

^a Duke University   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cell death; Natriuretic peptides; Nuclear matrix proteins; Pancreatic neoplasm; Prostate neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; ATRIAL NATRIURETIC FACTOR; KALIURETIC PEPTIDE; LONG ACTING NATRIURETIC PEPTIDE; NUCLEAR MATRIX PROTEIN; NUCLEAR MATRIX PROTEIN 41; NUCLEAR MATRIX PROTEIN 7; PEPTIDE HORMONE; UNCLASSIFIED DRUG; VESSEL DILATOR;

AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL DESTRUCTION;

ADENOCARCINOMA; AGED; ANTIGENS, NUCLEAR; ATRIAL NATRIURETIC FACTOR; CELL DEATH; CELL LINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY; LUNG; MALE; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN PRECURSORS;

EID: 79953234145     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hancock R and Boulikas T: Functional organization in the nucleus. Int Rev Cytol 79: 165-214, 1982.
2. Bouteille M, Bouvier D and Seve AP: Heterogeneity and territorial organization of the nuclear matrix and related structures. Int Rev Cytol 83: 135-182, 1983. (Pubitemid 14237806)
3. Berrios M, Osheroff N and Fisher PA: In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. Proc Natl Acad Sci USA 82: 4142-4146, 1985.
4. Zeitlin S, Parent A, Silverstein S and Efstratiadis A: Pre-mRNA splicing and the nuclear matrix. Mol Cell Biol 7: 111-120, 1987.
5. Nakayasu H and Berezney R: Mapping replicational sites in the eukaryotic cell nucleus. J Cell Biol 108: 1-11, 1989.
6. Vesely DL: Natriuretic hormones. In: The Kidney: Physiology and Pathophysiology, 4th edition. Alpern RJ and Herbert SC (eds.). San Diego, CA: Elsevier/Academic Press, pp. 947-977, 2007.
7. Vesely DL, Eichelbaum EJ, Sun Y, Alli AA, Vesely BA, Luther SL and Gower WR Jr.: Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. In Vivo 21: 445-452, 2007. (Pubitemid 46901402)
8. Vesely BA, McAfee Q, Gower WR Jr. and Vesely DL: Four peptides decrease the number of human pancreatic adenocarcinoma cells. Eur J Clin Invest 33: 998-1005, 2003. (Pubitemid 37421599)
9. Vesely BA, Alli AA, Song S, Gower WR Jr., Sanchez-Ramos J and Vesely DL: Four peptide hormones specific decrease (up to 97%) of human prostate carcinoma cells. Eur J Clin Invest 35: 700-710, 2005. (Pubitemid 41640906)
10. Gower WR Jr, Risch RM, Godellas CV, and Fabri PJ: HPAC, a new human glucocorticoid-sensitive pancreatic ductal adeno-carcinoma cell line. In Vitro Cell Dev Biol 30A: 151-161, 1994. (Pubitemid 24164794)
11. Stone KR, Mickey DD, Wunderli, H, Mickey GH and Paulson DF: Isolation of a human prostate carcinoma cell line (DU-145.) Int J Cancer 21: 284-281, 1978.
12. Yang CH, Lambie EJ and Snyder M: NuMA: an unusually long coiled-coil related protein in the mammalian nucleus. J Cell Biol 116: 1303-1317, 1992.
13. Vesely DL, Vesely BA, Eichelbaum EJ, Sun Y, Alli AA and Gower WR Jr.: Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice. In Vivo 21: 973-978, 2007. (Pubitemid 350286323)
14. Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr. and Vesely DL: Cardiac hormones and urodilatin eliminate up to 86% of human small-cell lung carcinomas in mice. Eur J Clin Invest 38: 562-570, 2008.
15. Sun Y, Eichelbaum EJ, Skelton WP IV, Lenz A, Regales N, Wang H and Vesely DL: Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 29: 971-975, 2009.
16. Sun Y, Eichelbaum EJ, Lenz A, Skelton WP IV, Wang H and Vesely DL: Atrial natriuretic peptide and long-acting natriuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 29: 1889-1893, 2009.
17. Sun Y, Eichelbaum EJ, Wang H and Vesely DL: Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27: 1387-1392, 2007. (Pubitemid 46807213)
18. Sun Y, Eichelbaum EJ, Wang H and Vesely DL: Atrial natriuretic peptide and long-acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27: 3813-3818, 2007.
19. Sun Y, Eichelbaum EJ, Wang H and Vesely DL: Vessel dilator and kaliuretic peptide inhibit activation of ERK 1/2 in human prostate cancer cells. Anticancer Res 26: 3217-3222, 2006.
20. Sun Y, Eichelbaum EJ, Wang H and Vesely DL: Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells. Anticancer Res 26: 4143-4148, 2006.
21. Sun Y, Eichelbaum EJ, Wang H and Vesely DL: Vessel dilator and kaliuretic peptide activate ERK 1/2 kinases in fibroblasts. Horm Metab Res 41: 197-201, 2009.